KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Payables (2017 - 2026)

Elanco Animal Health's Payables history spans 9 years, with the latest figure at $368.0 million for Q4 2025.

  • On a quarterly basis, Payables rose 24.32% to $368.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $368.0 million, a 24.32% increase, with the full-year FY2025 number at $368.0 million, up 24.32% from a year prior.
  • Payables hit $368.0 million in Q4 2025 for Elanco Animal Health, up from $352.0 million in the prior quarter.
  • Over the last five years, Payables for ELAN hit a ceiling of $506.0 million in Q2 2021 and a floor of $259.0 million in Q3 2024.
  • Historically, Payables has averaged $358.2 million across 5 years, with a median of $361.0 million in 2023.
  • Biggest five-year swings in Payables: surged 108.66% in 2021 and later crashed 30.77% in 2023.
  • Tracing ELAN's Payables over 5 years: stood at $416.0 million in 2021, then fell by 6.25% to $390.0 million in 2022, then crashed by 30.77% to $270.0 million in 2023, then increased by 9.63% to $296.0 million in 2024, then grew by 24.32% to $368.0 million in 2025.
  • Business Quant data shows Payables for ELAN at $368.0 million in Q4 2025, $352.0 million in Q3 2025, and $368.0 million in Q2 2025.